OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
Vasileios Fragoulakis, Rossana Roncato, Alessia Bignucolo, et al.
Pharmacological Research (2023) Vol. 197, pp. 106949-106949
Open Access | Times Cited: 12
Vasileios Fragoulakis, Rossana Roncato, Alessia Bignucolo, et al.
Pharmacological Research (2023) Vol. 197, pp. 106949-106949
Open Access | Times Cited: 12
Showing 12 citing articles:
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
R COOPERDEHOFF, D. Max Smith, Christina L. Aquilante, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
R COOPERDEHOFF, D. Max Smith, Christina L. Aquilante, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA ): Actionability and Comparison Across Other Regulatory Agencies
Antonino Moschella, Soumaya Mourou, Samantha Perfler, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Antonino Moschella, Soumaya Mourou, Samantha Perfler, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Systematic analysis of the pharmacogenomics landscape towards clinical implementation of precision therapeutics in Greece
George P. Patrinos, Kariofyllis Karamperis, Margarita-Ioanna Koufaki, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
George P. Patrinos, Kariofyllis Karamperis, Margarita-Ioanna Koufaki, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review
Mackenzie Bourke, Aideen M. McInerney‐Leo, Julia Steinberg, et al.
Applied Health Economics and Health Policy (2025)
Open Access
Mackenzie Bourke, Aideen M. McInerney‐Leo, Julia Steinberg, et al.
Applied Health Economics and Health Policy (2025)
Open Access
Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Candace Joefield-Roka, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 2
Open Access | Times Cited: 2
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Candace Joefield-Roka, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 2
Open Access | Times Cited: 2
Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice
Florine M. Wiss, Deborah Jakober, Markus L. Lampert, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 862-862
Open Access | Times Cited: 2
Florine M. Wiss, Deborah Jakober, Markus L. Lampert, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 862-862
Open Access | Times Cited: 2
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 2, pp. 79-95
Closed Access | Times Cited: 1
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 2, pp. 79-95
Closed Access | Times Cited: 1
Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs
John McDermott, Videha Sharma, William G. Newman, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 7, pp. 1699-1710
Open Access | Times Cited: 1
John McDermott, Videha Sharma, William G. Newman, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 7, pp. 1699-1710
Open Access | Times Cited: 1
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines
Xando Díaz-Villamarín, María Martínez Pérez, María Teresa Nieto-Sánchez, et al.
(2024)
Open Access
Xando Díaz-Villamarín, María Martínez Pérez, María Teresa Nieto-Sánchez, et al.
(2024)
Open Access
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study
Xando Díaz-Villamarín, María Jesús Martínez-Pérez, María Teresa Nieto-Sánchez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 956-956
Open Access
Xando Díaz-Villamarín, María Jesús Martínez-Pérez, María Teresa Nieto-Sánchez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 956-956
Open Access
Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort
Chunyu Wei, Ming‐Shien Wen, Chih-Kuang Cheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Chunyu Wei, Ming‐Shien Wen, Chih-Kuang Cheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort
Pui‐Yan Kwok, Ming‐Shien Wen, Chih-Kuang Cheng, et al.
(2024)
Closed Access
Pui‐Yan Kwok, Ming‐Shien Wen, Chih-Kuang Cheng, et al.
(2024)
Closed Access
